Evotec CSO Cord Dohrmann steps down
Share
- Evotec announced that Chief Scientific Officer Cord Dohrmann will leave the company on September 30, 2026.
- Dohrmann’s departure was agreed by mutual consent after serving as CSO and Management Board member since 2010.
- Evotec said the search for a successor is ongoing.
Evotec (NASDAQ:EVO) announced that Chief Scientific Officer Cord Dohrmann will step down from his role on September 30, 2026, by mutual consent.
Dohrmann has served as Evotec’s chief scientific officer and as a member of the company’s Management Board since 2010, overseeing scientific strategy and research activities.
Evotec said the search for a successor to Dohrmann is currently underway as the company prepares for a transition in scientific leadership.
Evotec is a biotechnology company focused on drug discovery and development partnerships with pharmaceutical and biotechnology companies.
The company did not provide additional details regarding the transition or the timeline for appointing a new chief scientific officer.
